Видео ютуба по тегу Immune-Oncology

Elen Baloyan on LMICs' Role in Immune Oncology Trials | ASCO 2024
Elen Baloyan on LMICs' Role in Immune Oncology Trials | ASCO 2024
Accelerate Cancer Immunotherapy Screening with Immune Checkpoint Reporter Cells
Accelerate Cancer Immunotherapy Screening with Immune Checkpoint Reporter Cells
Immuno-Oncology Market 2024: Innovations, Growth, and Trends in Cancer Immunotherapy and Treatments
Immuno-Oncology Market 2024: Innovations, Growth, and Trends in Cancer Immunotherapy and Treatments
Immuno-Oncology: A Focus on Bladder Cancer
Immuno-Oncology: A Focus on Bladder Cancer
AUA SIU Symposium Therapeutic Advances In Immuno - Oncology
AUA SIU Symposium Therapeutic Advances In Immuno - Oncology
Advancing Immune-Targeted Cancer Therapies: Leveraging Human Primary Cell in vitro Assays
Advancing Immune-Targeted Cancer Therapies: Leveraging Human Primary Cell in vitro Assays
Engineering Immune Cells for Cancer Treatment
Engineering Immune Cells for Cancer Treatment
Engineering Immune Cells for Cancer Treatment
Engineering Immune Cells for Cancer Treatment
CEEAO 2024 - Mario Mandala - Immune therapy in oncology - EN
CEEAO 2024 - Mario Mandala - Immune therapy in oncology - EN
CEEAO 2024 - Mario Mandala - Immune therapy in oncology - HU
CEEAO 2024 - Mario Mandala - Immune therapy in oncology - HU
4/4) Panel session: the Role of NBTXR3 and Immune Oncology in Advancing Head&Neck Cancer | 05.18.24
4/4) Panel session: the Role of NBTXR3 and Immune Oncology in Advancing Head&Neck Cancer | 05.18.24
Immunology And Immune Response to Cancer: Antigen presentation, Activation of Immune cells
Immunology And Immune Response to Cancer: Antigen presentation, Activation of Immune cells
Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024
Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024
The Year in Immuno-Oncology and What to Watch in 2018
The Year in Immuno-Oncology and What to Watch in 2018
27: Immuno-oncology 101 w/ Elfirede Nößner, HelmholzZentrum, Visiopharm advisor
27: Immuno-oncology 101 w/ Elfirede Nößner, HelmholzZentrum, Visiopharm advisor
Personalized cancer vaccines may train the body’s immune system to fight tumors
Personalized cancer vaccines may train the body’s immune system to fight tumors